AZTRAzitra, Inc.

NYSE azitrainc.com


$ 0.63 $ -0.01 (-1.09 %)    

Tuesday, 20-Aug-2024 14:02:12 EDT
QQQ $ 480.15 $ -1.15 (-0.24 %)
DIA $ 408.54 $ -0.55 (-0.13 %)
SPY $ 558.65 $ -0.51 (-0.09 %)
TLT $ 98.68 $ 0.38 (0.39 %)
GLD $ 232.46 $ 0.85 (0.37 %)
$ 0.635
$ 0.63
$ 0.63 x 444
-- x --
$ 0.63 - $ 0.63
$ 0.49 - $ 75.60
385,210
na
609,693
$ -26.03
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-12-2024 06-30-2024 10-Q
2 05-09-2024 03-31-2024 10-Q
3 03-15-2024 12-31-2023 10-K
4 11-14-2023 09-30-2023 10-Q
5 08-14-2023 06-30-2023 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 anitra-q2-2024-gaap-eps-274-misses-036-estimate-sales-75000k-down-from-172000k-yoy

Anitra (AMEX:AZTR) reported quarterly losses of $(2.74) per share which missed the analyst consensus estimate of $(0.36) by 661...

 azitra-shares-resumed-trade
Azitra Shares Resumed Trade
08/09/2024 15:15:59

 why-azitra-stock-is-crashing
Why Azitra Stock Is Crashing
07/24/2024 16:44:45

Azitra shares are crashing Wednesday after the company announced the pricing of a $10 million public offering of 6,665,000 comm...

 why-azitra-stock-is-moving-higher-on-tuesday

Azitra announced that the U.S. Patent and Trademark Office granted it's patent application regarding the treatment of atopi...

 azitra-strengthens-global-intellectual-property-portfolio-with-newly-granted-and-allowed-patents

Newly issued U.S. patent protects a filaggrin-secreting strain of Staphylococcus epidermidis for the treatment of atopic dermat...

 why-azitra-aztr-shares-are-down-29-today

Azitra shares are trading lower by 29% during Tuesday's session. The company announced a mixed shelf offering of up to $50 ...

 on-monday-july-1-2024-azitra-filed-for-mixed-shelf-offering-of-up-to-50m

- SEC Filing

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION